Journal of Alzheimer s Disease · 2018 · 63 citations · 41 references
MedicineNeurologyDementiaRisk AssessmentRisk CommunicationAlzheimer DiseaseDementia BiomarkersDementia CareDementia DiagnosisDementia Risk FactorsRisk AttitudesAlzheimer Disease DementiaAlzheimer Disease RiskAlzheimer's Disease CommunicationDisease BiomarkersEarly Detection Of DementiaFocus Group DiscussionsResponsible DisclosureRisk Assessment Information Disclosure
In clinical trials which target pathophysiological mechanisms associated with Alzheimer's disease, research participants who are recruited based on biomarker test results should be informed about their increased risk of developing Alzheimer's dementia. This paper presents the results of a qualitative focus group study of attitudes and concerns toward learning information about biomarker-based risk status among healthy research participants in the United Kingdom and Spain and people with dementia and their supporters/caregivers from countries represented in the European Working Group of People with Dementia of Alzheimer Europe. The study identified expectations related to learning risk status and preferences related to the content, quality, and follow-up of the disclosure process. The latter emphasize distinctions between risk and diagnoses, the importance of clear information about risk, and suggestions for risk reduction, as well as expectations for follow up and support. The implications of these preferences for practice are discussed. Providing details of research participants' experience and views may serve as a guide for the development of processes for the responsible disclosure of Alzheimer's disease biomarkers.
41
Reisa A. Sperling, Paul Aisen, Laurel Beckett et al. · Alzheimer s & Dementia · 2011 · 7.1K citations · Full text
Medicine, Neurology, Neuroscience +17
Hearing Loss and Cognitive Decline in Older Adults
JAMA Internal Medicine · 2013 · 3.8K citations
Age, Neuropathology, and Dementia
George M. Savva, Stephen B. Wharton, Paul G. Ince et al. · New England Journal of Medicine · 2009 · 895 citations · Full text
The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling, Dorene M. Rentz, Keith A. Johnson et al. · Science Translational Medicine · 2014 · 771 citations · Full text